Tag Archives: TAVR

Debemos tener en cuenta a la isquemia crítica de MM II en el TAVI

Critical Lower Limb Ischemia Should Be Taken into Account in TAVR

Critical Lower Limb Ischemia Should Be Taken into Account in TAVR

Courtesy of Dr. Carlos Fava. Peripheral vascular diseases (PVD) present the same risk factors as aortic stenosis. In consequence, these disorders usually coexist. The frequency and impact of their various stages on patients undergoing TAVR is yet to be thoroughly assessed. Read also: “Peripheral Vascular Disease Is Associated to More Events in TAVR”. This study analyzed

Intervenciones Percutáneas Post TAVI

Percutaneous Interventions After TAVR

Percutaneous Interventions After TAVR. Presenters: Dr. Fernando Cura, Argentina.  Dr. Samir Kapadia, Estados Unidos. This video, sponsored and funded by Medtronic, was filmed during SOLACI-CACI 2017 Congress, at Hilton Buenos Aires Hotel (in Argentina). Do you want to take a look at all other SOLACI-CACI 2017 Congress Medtronic cases? Watch them  We are interested in your opinion. Please, leave

TAVI: Casos de riesgo intermedio

TAVR: Cases of intermediate risk

TAVR: Cases of intermediate risk. Presenters: Dr. Oscar Méndiz, Argentina.  Dr. Carlos Calderas, Venezuela.  Dr. Anibal Damonte, Argentina. This video, sponsored and funded by Medtronic, was filmed during SOLACI-CACI 2017 Congress, at Hilton Buenos Aires Hotel (in Argentina). Do you want to take a look at all other SOLACI-CACI 2017 Congress Medtronic cases? Watch them  We are interested in

Cómo evitar el Patient Prosthesis Mismatch en el TAVI

How to Avoid Patient Prosthesis Mismatch in TAVR

How to Avoid Patient Prosthesis Mismatch in TAVR. Presenters: Dr. Joel Estrada Gallegos, México. Dr. Gutierrez Jaikel, Costa Rica. Dr. Juan Gaspar, Uruguay. This video, sponsored and funded by Medtronic, was filmed during SOLACI-CACI 2017 Congress, at Hilton Buenos Aires Hotel (in Argentina). Do you want to take a look at all other SOLACI-CACI 2017 Congress Medtronic cases? Watch

Impacto clínico de la regurgitación paravalvular post TAVI

Clinical Impact of Paravalvular Regurgitation After TAVR

Clinical Impact of Paravalvular Regurgitation After TAVR. Presenters: -Fernando Cura (Argentina).  -Gabriel Maluenda (Chile). This video, sponsored and funded by Medtronic, was filmed during SOLACI-CACI 2017 Congress, at Hilton Buenos Aires Hotel (in Argentina). Do you want to take a look at all other SOLACI-CACI 2017 Congress Medtronic cases? Watch them  We are interested in your opinion. Please, leave

Intervenciones percutáneas post-TAVI

Percutaneous Interventions After TAVR.

Percutaneous Interventions After TAVR. Presenters: -Dr. Matías Stejfman. -Dr. Gabriel Maluenda. This video, sponsored and funded by Medtronic, was filmed during SOLACI-CACI 2017 Congress, at Hilton Buenos Aires Hotel (in Argentina). Do you want to take a look at all other SOLACI-CACI 2017 Congress Medtronic cases? Watch them  We are interested in your opinion. Please, leave your comments, thoughts,

Tavi como procedimiento minimalista

TAVR as a Minimalist Procedure

TAVR as a Minimalist Procedure. Presenters: Dr. Paulo Caramori, Brasil.  Dr. Luis Gutierrez Jaikel. This video, sponsored and funded by Medtronic, was filmed during SOLACI-CACI 2017 Congress, at Hilton Buenos Aires Hotel (in Argentina). Do you want to take a look at all other SOLACI-CACI 2017 Congress Medtronic cases? Watch them  We are interested in your opinion.

Ventajas de la sedación consciente en el TAVI

The Perks of Conscious Sedation in TAVR

The main advantage of transcatheter aortic valve replacement (TAVR) has always been its less invasive nature, compared against surgery. Many of the advances in this technique revolve around making it even less invasive, increasing the gap between the two. The kind of anesthesia has been one of these many advances. There are several reports (in general from

TAVI en insuficiencia aórtica pura, nuevos dispositivos con nuevos resultados

TAVR in Pure Aortic Regurgitation: New Devices, New Outcomes

Pure aortic regurgitation has historically been considered a contraindication for transcatheter aortic valve replacement (TAVR) due to the absence of calcification and subsequent device anchoring problems it poses. Initial reports on first-generation self-expanding valves for the treatment of pure regurgitation were somewhat discouraging, but devices evolved, adding repositioning capacity, different external skirts (pericardial, PET, urethane,

Estenosis aórtica pura vs mixta en TAVI: beneficios y evolución

TAVR in Patients with Pure vs. Mixed Aortic Stenosis: Benefits and Evolution

Courtesy of Dr. Carlos Fava. Transcatheter aortic valve replacement (TAVR) has been proven to reduce mortality and improve the quality of life of patients with pure severe aortic stenosis (PAS). However, there is a significant number of patients who experience mixed aortic stenosis associated with moderate/severe aortic regurgitation (MAS). These subjects were excluded from the PARTNER

Top